demonstrated an unexpected trend toward increased PFS risk (HR =1.38, 95% CI: 0.84–2.29), with all 95% confidence intervals encompassing the null value ( 29 ).
← all excerpts
Statins as potential adjuvant therapy in lung cancer: a narrative review.
1
—
—